To date, the majority of pediatric brain tumor GEMMs are SHH-activated medulloblastoma (Table 1), which are generated by modifying SHH signaling genes, such as PTCH, SMO, or SUFU (22, 24). The gene discussed is SMO; the disease is medulloblastoma.